Microsoft’s $250B Azure Bet: The Real Story Behind OpenAI Deal
Related Posts
GSK Bets £45 Million on AI to Fight Superbugs
Pharmaceutical giant GSK is launching a £45 million AI initiative to combat antimicrobial resistance, targeting pathogens like MRSA and climate-driven fungi. The partnership with the Fleming Initiative will fund 50 researchers across six programs as drug-resistant infections surge globally.
FTC’s AI Policy Erasure: How Vanishing Blog Posts Reflect Shifting Regulatory Winds
The Disappearing Act at America’s Consumer Protection Agency In a quiet but significant digital purge, the Federal Trade Commission has…
Microsoft’s Gaming Copilot AI Training Raises Privacy Concerns: How to Protect Your Gameplay Data
Windows 11’s Silent Observer: Gaming Copilot’s Data Collection Practices Microsoft’s recently introduced Gaming Copilot AI feature in Windows 11 has…